Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) EBT Margin: 2021

Historic EBT Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Dec 2021 value amounting to 63.08%.

  • Atea Pharmaceuticals' EBT Margin was N/A to 63.08% in Q4 2021 from the same period last year, while for Dec 2021 it was 39.44%, marking a year-over-year change of. This contributed to the annual value of 39.44% for FY2021, which is 6195.00% up from last year.
  • Atea Pharmaceuticals' EBT Margin amounted to 63.08% in Q4 2021, which was up 193.68% from -67.34% recorded in Q3 2021.
  • In the past 5 years, Atea Pharmaceuticals' EBT Margin registered a high of 63.08% during Q4 2021, and its lowest value of -67.34% during Q3 2021.
  • Over the past 1 years, Atea Pharmaceuticals' median EBT Margin value was 30.51% (recorded in 2021), while the average stood at 14.19%.